High precision imaging of microscopic spread of glioblastoma with a targeted ultrasensitive SERRS molecular imaging probe

Theranostics

Volumn 6, Issue 8, 2016, Pages 1075-1084

  Huang, Ruimin ^a   Harmsen, Stefan ^a   Samii, Jason M ^a   Karabeber, Hazem ^a   Pitter, Kenneth L ^a   Holland, Eric C ^b   Kircher, Moritz F ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Brain tumor treatment; Image guided surgery; Neurosurgery; Raman spectroscopy; SERRS molecular imaging

Indexed keywords

ARGININEGLYCINEASPARTIC ACID NANOPARTICLE; ARGINYLALANYLASPARTIC ACID NANOPARTICLE; BETA3 INTEGRIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PEPTIDE NANOTUBE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; ARGINYL-GLYCYL-ASPARTIC ACID; INTEGRIN; NANOPARTICLE; OLIGOPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EX VIVO STUDY; GLIOBLASTOMA; HISTOLOGY; IMAGE ANALYSIS; IMAGE PROCESSING; IN VIVO STUDY; LIMIT OF DETECTION; MOUSE; NONHUMAN; PARTICLE SIZE; PROTEIN EXPRESSION; RAMAN SPECTROMETRY; SENSITIVITY AND SPECIFICITY; TUMOR INVASION; ANIMAL; BRAIN TUMOR; DISEASE MODEL; MOLECULAR IMAGING; PATHOLOGY; PROCEDURES;

ANIMALS; BRAIN NEOPLASMS; DISEASE MODELS, ANIMAL; GLIOBLASTOMA; INTEGRINS; MICE; MOLECULAR IMAGING; NANOPARTICLES; OLIGOPEPTIDES; SPECTRUM ANALYSIS, RAMAN;

EID: 84984698621     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.13842     Document Type: Article

References (56)

1. Holland EC. Glioblastoma multiforme: the terminator. Proceedings of the National Academy of Sciences of the United States of America. 2000; 97: 6242-4.
2. Adamson C, Kanu OO, Mehta AI, Di C, Lin N, Mattox AK, et al. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs. 2009; 18: 1061-83.
3. Hoover JM, Chang SM, Parney IF. Clinical trials in brain tumor surgery. Neuroimaging Clin N Am. 2010; 20: 409-24.
4. Bucci MK, Maity A, Janss AJ, Belasco JB, Fisher MJ, Tochner ZA, et al. Near complete surgical resection predicts a favorable outcome in pediatric patients with nonbrainstem, malignant gliomas: results from a single center in the magnetic resonance imaging era. Cancer. 2004; 101: 817-24.
5. Ngwenya LB, Chiocca EA. Extent of resection. Journal of neurosurgery. 2011; 115: 1-2; discussion
6. Stupp R, Hegi ME, van den Bent MJ, Mason WP, Weller M, Mirimanoff RO, et al. Changing paradigms--an update on the multidisciplinary management of malignant glioma. Oncologist. 2006; 11: 165-80.
7. Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. Journal of neurosurgery. 2011; 115: 3-8.
8. Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, et al. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. Journal of neurosurgery. 2012; 117: 1032-8.
9. Petrecca K, Guiot MC, Panet-Raymond V, Souhami L. Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma. Journal of neuro-oncology. 2013; 111: 19-23.
10. Oh J, Sahgal A, Sanghera P, Tsao MN, Davey P, Lam K, et al. Glioblastoma: patterns of recurrence and efficacy of salvage treatments. The Canadian journal of neurological sciences Le journal canadien des sciences neurologiques. 2011; 38: 621-5.
11. Gerstner ER, Chen PJ, Wen PY, Jain RK, Batchelor TT, Sorensen G. Infiltrative Patterns of Glioblastoma Spread Detected via Diffusion MRI After Treatment with Cediranib. Neuro-oncology. 2010; 12: 466-72.
12. de Groot JF, Fuller G, Kumar AJ, Piao Y, Eterovic K, Ji Y, et al. Tumor Invasion after Treatment of Glioblastoma with Bevacizumab: Radiographic and Pathologic Correlationin Humans and Mice. Neuro-oncology. 2010; 12: 233-42.
13. Kircher MF, de la Zerda A, Jokerst JV, Zavaleta CL, Kempen PJ, Mittra E, et al. A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nature medicine. 2012; 18: 829-34.
14. Reinges MH, Nguyen HH, Krings T, Hutter BO, Rohde V, Gilsbach JM. Course of brain shift during microsurgical resection of supratentorial cerebral lesions: limits of conventional neuronavigation. Acta Neurochir (Wien). 2004; 146: 369-77; discussion 77.
15. Knauth M, Aras N, Wirtz CR, Dorfler A, Engelhorn T, Sartor K. Surgically induced intracranial contrast enhancement: potential source of diagnostic error in intraoperative MR imaging. AJNR Am J Neuroradiol. 1999; 20: 1547-53.
16. Ludemann L, Hamm B, Zimmer C. Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging. Magn Reson Imaging. 2000; 18: 1201-14.
17. Pronin IN, McManus KA, Holodny AI, Peck KK, Kornienko VN. Quantification of dispersion of Gd-DTPA from the initial area of enhancement into the peritumoral zone of edema in brain tumors. Journal of neuro-oncology. 2009; 94: 399-408.
18. Saether CA, Torsteinsen M, Torp SH, Sundstrom S, Unsgard G, Solheim O. Did survival improve after the implementation of intraoperative neuronavigation and 3D ultrasound in glioblastoma surgery? A retrospective analysis of 192 primary operations. Journal of neurological surgery Part A, Central European neurosurgery. 2012; 73: 73-8.
19. Ulrich NH, Burkhardt JK, Serra C, Bernays RL, Bozinov O. Resection of pediatric intracerebral tumors with the aid of intraoperative real-time 3-D ultrasound. Child's nervous system: ChNS: official journal of the International Society for Pediatric Neurosurgery. 2012; 28: 101-9.
20. Beljebbar A, Dukic S, Amharref N, Manfait M. Ex vivo and in vivo diagnosis of C6 glioblastoma development by Raman spectroscopy coupled to a microprobe. Anal Bioanal Chem. 2010; 398: 477-87.
21. Toms SA, Lin WC, Weil RJ, Johnson MD, Jansen ED, Mahadevan-Jansen A. Intraoperative optical spectroscopy identifies infiltrating glioma margins with high sensitivity. Neurosurgery. 2005; 57: 382-91; discussion -91.
22. Ji M, Orringer DA, Freudiger CW, Ramkissoon S, Liu X, Lau D, et al. Rapid, Label-Free Detection of Brain Tumors with Stimulated Raman Scattering Microscopy. Science translational medicine. 2013; 5: 201ra119.
23. Ozawa T, Britz GW, Kinder DH, Spence AM, VandenBerg S, Lamborn KR, et al. Bromophenol blue staining of tumors in a rat glioma model. Neurosurgery. 2005; 57: 1041-7; discussion -7.
24. Shinoda J, Yano H, Yoshimura S, Okumura A, Kaku Y, Iwama T, et al. Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note. Journal of neurosurgery. 2003; 99: 597-603.
25. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ, et al. Fluorescence-Guided Surgery with 5-Aminolevulinic Acid for Resection of Malignant Glioma: A Randomised Controlled Multicentre Phase III Trial. The lancet oncology. 2006; 7: 392-401.
26. Huang R, Vider J, Kovar JL, Olive DM, Mellinghoff IK, Mayer-Kuckuk P, et al. Integrin alphavbeta3-targeted IRDye 800CW near-infrared imaging of glioblastoma. Clin Cancer Res. 2012; 18: 5731-40.
27. Kantelhardt SR, Diddens H, Leppert J, Rohde V, Huttmann G, Giese A. Multiphoton excitation fluorescence microscopy of 5-aminolevulinic acid induced fluorescence in experimental gliomas. Lasers Surg Med. 2008; 40: 273-81.
28. de la Zerda A, Bodapati S, Teed R, Schipper ML, Keren S, Smith BR, et al. A comparison between time domain and spectral imaging systems for imaging quantum dots in small living animals. Molecular imaging and biology: MIB: the official publication of the Academy of Molecular Imaging. 2010; 12: 500-8.
29. Harmsen S, Bedics MA, Wall MA, Huang R, Detty MR, Kircher MF. Rational design of a chalcogenopyrylium-based surface-enhanced resonance Raman scattering nanoprobe with attomolar sensitivity. Nat Commun. 2015; 6: 6570.
30. Harmsen S, Huang R, Wall MA, Karabeber H, Samii JM, Spaliviero M, et al. Surface-enhanced resonance Raman scattering nanostars for high-precision cancer imaging. Science translational medicine. 2015; 7: 271ra7.
31. Spaliviero M, Harmsen S, Huang R, Wall MA, Andreou C, Eastham JA, et al. Detection of Lymph Node Metastases with SERRS Nanoparticles. Molecular imaging and biology: MIB: the official publication of the Academy of Molecular Imaging. 2016.
32. Tabatabai G, Weller M, Nabors B, Picard M, Reardon D, Mikkelsen T, et al. Targeting integrins in malignant glioma. Target Oncol. 2010; 5: 175-81.
33. Barrett LE, Granot Z, Coker C, Iavarone A, Hambardzumyan D, Holland EC, et al. Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma. Cancer cell. 2012; 21: 11-24.
34. Hambardzumyan D, Amankulor NM, Helmy KY, Becher OJ, Holland EC. Modeling Adult Gliomas Using RCAS/t-va Technology. Transl Oncol. 2009; 2: 89-95.
35. Hambardzumyan D, Parada LF, Holland EC, Charest A. Genetic modeling of gliomas in mice: new tools to tackle old problems. Glia. 2011; 59: 1155-68.
36. Uhrbom L, Holland EC. Modeling gliomagenesis with somatic cell gene transfer using retroviral vectors. Journal of neuro-oncology. 2001; 53: 297-305.
37. Uhrbom L, Kastemar M, Johansson FK, Westermark B, Holland EC. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis. Cancer Res. 2005; 65: 2065-9.
38. Karabeber H, Huang R, Iacono P, Samii JM, Pitter K, Holland EC, et al. Guiding brain tumor resection using surface-enhanced Raman scattering nanoparticles and a hand-held Raman scanner. ACS Nano. 2014; 8: 9755-66.
39. Garai E, Sensarn S, Zavaleta CL, Loewke NO, Rogalla S, Mandella MJ, et al. A real-time clinical endoscopic system for intraluminal, multiplexed imaging of surface-enhanced Raman scattering nanoparticles. PLoS One. 2015; 10: e0123185.
40. Tichauer KM, Wang Y, Pogue BW, Liu JT. Quantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imaging. Phys Med Biol. 2015; 60: R239-69.
41. Katz AM, Amankulor NM, Pitter K, Helmy K, Squatrito M, Holland EC. Astrocyte-specific expression patterns associated with the PDGF-induced glioma microenvironment. PLoS One. 2012; 7: e32453.
42. Peiffer J, Kleihues P. Hans-Joachim Scherer (1906-1945), pioneer in glioma research. Brain Pathol. 1999; 9: 241-5.
43. Claes A, Idema AJ, Wesseling P. Diffuse glioma growth: a guerilla war. Acta Neuropathol. 2007; 114: 443-58.
44. Thakor AS, Gambhir SS. Nanooncology: the future of cancer diagnosis and therapy. CA: a cancer journal for clinicians. 2013; 63: 395-418.
45. Lee HY, Li Z, Chen K, Hsu AR, Xu C, Xie J, et al. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J Nucl Med. 2008; 49: 1371-9.
46. Zhang F, Huang X, Zhu L, Guo N, Niu G, Swierczewska M, et al. Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles. Biomaterials. 2012; 33: 5414-22.
47. Zavaleta CL, Kircher MF, Gambhir SS. Raman's "Effect" on Molecular Imaging. J Nucl Med. 2011; 52: 1839-44.
48. Liu JT, Meza D, Sanai N. Trends in fluorescence image-guided surgery for gliomas. Neurosurgery. 2014; 75: 61-71.
49. Rogers L, Pueschel J, Spetzler R, Shapiro W, Coons S, Thomas T, et al. Is Gross-Total Resection Sufficient Treatment for Posterior Fossa Ependymomas? Journal of neurosurgery. 2005; 102: 629-36.
50. Pfister S, Witt O. Pediatric Gliomas. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer. 2009; 171: 67-81.
51. Pollack IF. Brain Tumors in Children. The New England journal of medicine. 1994; 331: 1500-7.
52. Lim M, Guccione S, Haddix T, Sims L, Cheshier S, Chu P, et al. alpha(v)beta(3) Integrin in central nervous system tumors. Hum Pathol. 2005; 36: 665-9.
53. Schnell O, Krebs B, Wagner E, Romagna A, Beer AJ, Grau SJ, et al. Expression of integrin alphavbeta3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature. Brain Pathol. 2008; 18: 378-86.
54. Thakor AS, Luong R, Paulmurugan R, Lin FI, Kempen P, Zavaleta C, et al. The fate and toxicity of Raman-active silica-gold nanoparticles in mice. Science translational medicine. 2011; 3: 79ra33.
55. Andreou C, Kishore SA, Kircher MF. Surface-Enhanced Raman Spectroscopy: A New Modality for Cancer Imaging. J Nucl Med. 2015; 56: 1295-9.
56. Bohndiek SE, Wagadarikar A, Zavaleta CL, Van de Sompel D, Garai E, Jokerst JV, et al. A small animal Raman instrument for rapid, wide-area, spectroscopic imaging. Proceedings of the National Academy of Sciences of the United States of America. 2013; 110: 12408-13.